Pricing Log in Create free account

Curis, Inc. (CRIS) vs Altamira Therapeutics Ltd. (CYTOF)

Curis, Inc. and Altamira Therapeutics Ltd. are both Biotechnology companies. Curis, Inc. and Altamira Therapeutics Ltd. are of similar size ($1.1M and $1.1M). Across the 9 metrics below, Curis, Inc. leads on 7 and Altamira Therapeutics Ltd. on 2.

Valuation

Metric CRIS CYTOF Biotechnology median
P/E n/m n/m 8.50
P/S 0.09 n/m 9.71
P/B 0.19 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.41 n/m 0.64
EV/Sales (0.37) n/m 9.21
Earnings yield (3,468.29%) (44,544.44%) (33.15%)
Free cash flow yield (3,540.29%) (9,080,722.22%) (25.50%)

Profitability

Metric CRIS CYTOF Biotechnology median
Gross margin 99.52% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 455.35% 0.00% (56.36%)
Return on assets (87.76%) 0.00% (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CRIS CYTOF Biotechnology median
Revenue growth (TTM) (13.43%) — 6.02%
EPS growth (last fiscal year) 91.57% 81.52% 30.26%
Revenue growth, 5-year CAGR (2.71%) — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CRIS CYTOF Biotechnology median
Debt to equity 0.00 0.11 0.00
Current ratio 0.49 0.11 4.72
Net debt to EBITDA 0.91 (0.27) 0.96

Dividend

Metric CRIS CYTOF Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CRIS CYTOF Biotechnology median
Market cap 1.06m 1.13m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack